In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Idexx Laboratories, Inc (NASDAQ: IDXX) closed the day trading at $423.99 up 1.25% from the previous closing price of $418.75. In other words, the price has increased by $1.25 from its previous closing price. On the day, 0.51 million shares were traded. IDXX stock price reached its highest trading level at $431.38 during the session, while it also had its lowest trading level at $420.86.
Ratios:
For a better understanding of IDXX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 112.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 43.80. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.36. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on December 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $500.
On July 25, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $580.
Piper Sandler Downgraded its Overweight to Neutral on January 30, 2024, while the target price for the stock was maintained at $525.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 27 ’24 when Vandebroek Sophie V. sold 344 shares for $420.44 per share. The transaction valued at 144,630 led to the insider holds 905 shares of the business.
Vandebroek Sophie V. bought 344 shares of IDXX for $144,630 on Nov 27 ’24. On Sep 06 ’24, another insider, SZOSTAK M ANNE, who serves as the Director of the company, sold 500 shares for $469.37 each. As a result, the insider received 234,686 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDXX now has a Market Capitalization of 34718294016 and an Enterprise Value of 34978848768. As of this moment, Idexx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 40.91, and their Forward P/E ratio for the next fiscal year is 35.46. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.03 while its Price-to-Book (P/B) ratio in mrq is 21.50. Its current Enterprise Value per Revenue stands at 9.098 whereas that against EBITDA is 26.919.
Stock Price History:
The Beta on a monthly basis for IDXX is 1.37, which has changed by -0.20561898 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, IDXX has reached a high of $583.39, while it has fallen to a 52-week low of $398.50. The 50-Day Moving Average of the stock is 0.02%, while the 200-Day Moving Average is calculated to be -9.49%.
Shares Statistics:
Over the past 3-months, IDXX traded about 679.77K shares per day on average, while over the past 10 days, IDXX traded about 817370 shares per day. A total of 82.04M shares are outstanding, with a floating share count of 81.06M. Insiders hold about 1.00% of the company’s shares, while institutions hold 91.63% stake in the company. Shares short for IDXX as of 1736899200 were 1729921 with a Short Ratio of 2.54, compared to 1734048000 on 1398653. Therefore, it implies a Short% of Shares Outstanding of 1729921 and a Short% of Float of 2.7199999999999998.
